Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Adult fibroblasts help heart cells mature and improve heart function.

Skin cell-derived vesicles can help heal skin injuries effectively.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Stem cell treatments may improve burn wound healing.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

The niche environment controls stem cell behavior and plasticity, which is important for tissue health and repair.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Mesenchymal stem cells help improve skin healing and rejuvenation.

MSC-derived EVs have potential as therapeutic agents but face challenges like production complexity and high costs.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Hydrogel microcapsules help create cells that boost hair growth.

Vimentin is crucial for wound healing, cell growth, and managing immune responses.

Low doses of Asiasari radix extract boost stem cell growth without changing their shape.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

Araliadiol protects skin cells from damage by boosting antioxidant defenses.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.